Health & Wellness GSK small-cell lung cancer drug gets nod from European Medicines Agency Chinese-based Hansoh Pharma is conducting the trial to evaluate GSK'227 in patients with locally advanced or metastatic solid tumours Joseph MortonDecember 17, 2024
Health & Wellness Planning to burn scented candles this Christmas? You may want to reconsider New research has highlighted that they can increase your risk of lung cancer Rowan DunneDecember 11, 2024
Health & Wellness New blood test capable of screening for over 50 cancers available in Canada The Galleri test works by analyzing DNA fragments shed by cancer cells into the bloodstream Joseph MortonDecember 5, 2024
Health & Wellness Cross Country Healthcare jumps spike over 60% on merger news The deal represents a 67 per cent premium to Cross Country's closing price on December 3, 2024 Joseph MortonDecember 4, 2024
Health & Wellness India gets much needed lung cancer screening program The nation is facing a lung cancer epidemic from the heavy pollution Rowan DunneNovember 29, 2024
Health & Wellness BC woman advocates for lung cancer screening after shocking diagnosis at 39 Even if you have a healthy lifestyle and don't smoke you should still get checked out, she says Rowan DunneNovember 28, 2024
Health & Wellness Poseida Therapeutics shares skyrocket on acquisition from pharma-giant Roche Poseida's proprietary non-viral gene engineering technology has delivered promising early clinical results Joseph MortonNovember 26, 2024
Health & Wellness Robotic-assist and other tech spark demand in lung cancer surgery market The key developments are led by advances in robotic-assisted surgical systems and imaging technologies Joseph MortonNovember 25, 2024
Health & Wellness American Lung Association urges high-risk individuals to get lung cancer screening Only 16.0 per cent of eligible individuals underwent lung cancer screening in 2022 Joseph MortonNovember 20, 2024
Health & Wellness Jessica Alba’s natural baby product supplier surges on strong Q3 results The Honest Company has US$53 million in cash and no debt Rowan DunneNovember 13, 2024